SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009870584> ?p ?o ?g. }

Showing items 1 to 100 of ±129 with 100 items per page.

W3009870584 endingPage "112196" @default.
W3009870584 startingPage "112196" @default.
W3009870584 abstract "Prostate cancer (PC) is the most diagnosed type of malignancy in men and the major frequently cause of cancer-related death worldwide. The androgen receptor (AR) has become a promising drug target for the treatment of PC. Here, we reported the design, optimization and evaluation of pyridine tetrahydroisoquinoline thiohydantoin derivatives with improved activity and safety as potent AR antagonists. The most promising compound 42f exhibited potent inhibitory activity on AR and strongly blocked AR nuclear translocation. Moreover, 42f displayed promising in vitro antitumor activity toward AR-dependent prostate cancer cell lines (LNCaP) and also demonstrated therapeutic effects in LNCaP xenograft tumor model in mice (TGI: 79%) with no apparent toxicity observed in vivo. More importantly, 42f showed negligible penetration of the brain-blood barrier (BBB) compared with enzalutamide. These results provide a foundation for the development of a new class of androgen receptor antagonists for potential therapeutics against PC with lower seizurogenic risk for patients." @default.
W3009870584 created "2020-03-13" @default.
W3009870584 creator A5004068069 @default.
W3009870584 creator A5018588998 @default.
W3009870584 creator A5022544178 @default.
W3009870584 creator A5028976572 @default.
W3009870584 creator A5034052235 @default.
W3009870584 creator A5045934445 @default.
W3009870584 creator A5050252340 @default.
W3009870584 creator A5057272360 @default.
W3009870584 creator A5060191439 @default.
W3009870584 creator A5060998288 @default.
W3009870584 creator A5063949124 @default.
W3009870584 creator A5066909518 @default.
W3009870584 creator A5071540782 @default.
W3009870584 creator A5085935520 @default.
W3009870584 date "2020-04-01" @default.
W3009870584 modified "2023-10-14" @default.
W3009870584 title "Discovery of pyridine tetrahydroisoquinoline thiohydantoin derivatives with low blood-brain barrier penetration as the androgen receptor antagonists" @default.
W3009870584 cites W1525230438 @default.
W3009870584 cites W1984887377 @default.
W3009870584 cites W1985580668 @default.
W3009870584 cites W1997766641 @default.
W3009870584 cites W2004023311 @default.
W3009870584 cites W2009337680 @default.
W3009870584 cites W2077923297 @default.
W3009870584 cites W2081365151 @default.
W3009870584 cites W2084637523 @default.
W3009870584 cites W2119504728 @default.
W3009870584 cites W2126959871 @default.
W3009870584 cites W2130189600 @default.
W3009870584 cites W2142793732 @default.
W3009870584 cites W2152067759 @default.
W3009870584 cites W2155758517 @default.
W3009870584 cites W2166918329 @default.
W3009870584 cites W2239698670 @default.
W3009870584 cites W2398079044 @default.
W3009870584 cites W2533240567 @default.
W3009870584 cites W2591825104 @default.
W3009870584 cites W2598787247 @default.
W3009870584 cites W2613332942 @default.
W3009870584 cites W2761124073 @default.
W3009870584 cites W2792086148 @default.
W3009870584 cites W2891714822 @default.
W3009870584 cites W2900742550 @default.
W3009870584 doi "https://doi.org/10.1016/j.ejmech.2020.112196" @default.
W3009870584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32169785" @default.
W3009870584 hasPublicationYear "2020" @default.
W3009870584 type Work @default.
W3009870584 sameAs 3009870584 @default.
W3009870584 citedByCount "7" @default.
W3009870584 countsByYear W30098705842021 @default.
W3009870584 countsByYear W30098705842022 @default.
W3009870584 countsByYear W30098705842023 @default.
W3009870584 crossrefType "journal-article" @default.
W3009870584 hasAuthorship W3009870584A5004068069 @default.
W3009870584 hasAuthorship W3009870584A5018588998 @default.
W3009870584 hasAuthorship W3009870584A5022544178 @default.
W3009870584 hasAuthorship W3009870584A5028976572 @default.
W3009870584 hasAuthorship W3009870584A5034052235 @default.
W3009870584 hasAuthorship W3009870584A5045934445 @default.
W3009870584 hasAuthorship W3009870584A5050252340 @default.
W3009870584 hasAuthorship W3009870584A5057272360 @default.
W3009870584 hasAuthorship W3009870584A5060191439 @default.
W3009870584 hasAuthorship W3009870584A5060998288 @default.
W3009870584 hasAuthorship W3009870584A5063949124 @default.
W3009870584 hasAuthorship W3009870584A5066909518 @default.
W3009870584 hasAuthorship W3009870584A5071540782 @default.
W3009870584 hasAuthorship W3009870584A5085935520 @default.
W3009870584 hasConcept C121608353 @default.
W3009870584 hasConcept C126322002 @default.
W3009870584 hasConcept C150903083 @default.
W3009870584 hasConcept C185592680 @default.
W3009870584 hasConcept C207001950 @default.
W3009870584 hasConcept C2776406546 @default.
W3009870584 hasConcept C2776551883 @default.
W3009870584 hasConcept C2778402981 @default.
W3009870584 hasConcept C2779723316 @default.
W3009870584 hasConcept C2780192828 @default.
W3009870584 hasConcept C502942594 @default.
W3009870584 hasConcept C529278444 @default.
W3009870584 hasConcept C61367390 @default.
W3009870584 hasConcept C71240020 @default.
W3009870584 hasConcept C71924100 @default.
W3009870584 hasConcept C86803240 @default.
W3009870584 hasConcept C96232424 @default.
W3009870584 hasConcept C98274493 @default.
W3009870584 hasConceptScore W3009870584C121608353 @default.
W3009870584 hasConceptScore W3009870584C126322002 @default.
W3009870584 hasConceptScore W3009870584C150903083 @default.
W3009870584 hasConceptScore W3009870584C185592680 @default.
W3009870584 hasConceptScore W3009870584C207001950 @default.
W3009870584 hasConceptScore W3009870584C2776406546 @default.
W3009870584 hasConceptScore W3009870584C2776551883 @default.
W3009870584 hasConceptScore W3009870584C2778402981 @default.
W3009870584 hasConceptScore W3009870584C2779723316 @default.
W3009870584 hasConceptScore W3009870584C2780192828 @default.
W3009870584 hasConceptScore W3009870584C502942594 @default.